Drugs / 123-I MNI-308
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00544453 | Oct 2007 | Alzheimer disease | Molecular NeuroImaging | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 123-I MNI-308 | “To perform blood metabolite characterization of 123-I MNI-308 in healthy and AD subjects to determine the metabolic fate and nature of metabolites in assessment of 123-I...” NCT00544453 ↗ |
| Modality | Diagnostic / imaging agent | “single photon computed tomography (SPECT) brain imaging agent” NCT00544453 ↗ |